• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部鳞状细胞癌基因组研究的治疗见解

Therapeutic insights from genomic studies of head and neck squamous cell carcinomas.

作者信息

Hammerman Peter S, Hayes D Neil, Grandis Jennifer R

机构信息

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Cancer Program, Broad Institute of Harvard and MIT, Cambridge, Massachusetts.

Department of Hematology/Oncology, University of North Carolina Lineberger Cancer Center, Chapel Hill, North Carolina.

出版信息

Cancer Discov. 2015 Mar;5(3):239-44. doi: 10.1158/2159-8290.CD-14-1205. Epub 2015 Feb 2.

DOI:10.1158/2159-8290.CD-14-1205
PMID:25643909
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4355279/
Abstract

Large and comprehensive genomic surveys of head and neck squamous cell carcinomas (HNSCC) are now greatly increasing our understanding of the diversity of this disease and the key genomic changes that drive these tumors. The results from these studies are beginning to inform the introduction of novel therapies for patients with HNSCCs. Here, we review some of the key findings from recent genomic studies of head and neck cancers, including the most comprehensive study to date from The Cancer Genome Atlas Network.

摘要

对头颈部鳞状细胞癌(HNSCC)进行的大规模综合基因组调查,正极大地增进我们对这种疾病多样性以及驱动这些肿瘤发生的关键基因组变化的理解。这些研究结果开始为HNSCC患者引入新疗法提供依据。在此,我们回顾近期头颈癌基因组研究的一些关键发现,包括癌症基因组图谱网络(The Cancer Genome Atlas Network)迄今为止最全面的研究。

相似文献

1
Therapeutic insights from genomic studies of head and neck squamous cell carcinomas.头颈部鳞状细胞癌基因组研究的治疗见解
Cancer Discov. 2015 Mar;5(3):239-44. doi: 10.1158/2159-8290.CD-14-1205. Epub 2015 Feb 2.
2
Molecular Aspects of Head and Neck Cancer Therapy.头颈癌治疗的分子层面
Hematol Oncol Clin North Am. 2015 Dec;29(6):971-92. doi: 10.1016/j.hoc.2015.07.003. Epub 2015 Oct 17.
3
TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.TRAF3/CYLD突变可鉴定出人类乳头瘤病毒相关头颈部鳞状细胞癌的一个独特亚群。
Cancer. 2017 May 15;123(10):1778-1790. doi: 10.1002/cncr.30570. Epub 2017 Mar 13.
4
Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.人乳头瘤病毒阳性和阴性头颈部鳞状细胞癌的综合与比较基因组分析
Clin Cancer Res. 2015 Feb 1;21(3):632-41. doi: 10.1158/1078-0432.CCR-13-3310. Epub 2014 Jul 23.
5
Novel treatments for head and neck squamous cell carcinoma: preclinical identification and clinical investigation.头颈部鳞状细胞癌的新型治疗方法:临床前鉴定与临床研究。
Future Oncol. 2014 May;10(6):1065-80. doi: 10.2217/fon.14.18.
6
[Genomic characterization of head and neck squamous cell carcinoma: Impact and challenges for therapeutic management].[头颈部鳞状细胞癌的基因组特征:对治疗管理的影响与挑战]
Bull Cancer. 2018 Sep;105(9):820-829. doi: 10.1016/j.bulcan.2018.05.011. Epub 2018 Jun 22.
7
Clinical update on head and neck cancer: molecular biology and ongoing challenges.头颈部癌症的临床新进展:分子生物学和当前面临的挑战。
Cell Death Dis. 2019 Jul 15;10(8):540. doi: 10.1038/s41419-019-1769-9.
8
Leveraging Genomics for Head and Neck Cancer Treatment.利用基因组学进行头颈部癌症治疗。
J Dent Res. 2018 Jun;97(6):603-613. doi: 10.1177/0022034518756352. Epub 2018 Feb 8.
9
Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.经典风险因素而非人乳头瘤病毒(HPV)状态可预测晚期头颈癌患者放化疗后的生存率。
J Cancer Res Clin Oncol. 2016 Oct;142(10):2185-96. doi: 10.1007/s00432-016-2203-7. Epub 2016 Jul 1.
10
Human Papillomavirus and Potentially Relevant Biomarkers in Tonsillar and Base of Tongue Squamous Cell Carcinoma.人乳头瘤病毒与扁桃体及舌根鳞状细胞癌中潜在相关生物标志物
Anticancer Res. 2017 Oct;37(10):5319-5328. doi: 10.21873/anticanres.11958.

引用本文的文献

1
Prevalence and biological impact of clinically relevant gene fusions in head and neck cancers.头颈部癌症中临床相关基因融合的患病率及生物学影响
NPJ Precis Oncol. 2025 Jul 3;9(1):221. doi: 10.1038/s41698-025-00889-7.
2
Comprehensive characterization of the molecular feature of T cells in laryngeal cancer: evidence from integrated single-cell and bulk RNA sequencing data using multiple machine learning approaches.喉癌中T细胞分子特征的综合表征:来自使用多种机器学习方法整合单细胞和批量RNA测序数据的证据
Ann Med. 2025 Dec;57(1):2477287. doi: 10.1080/07853890.2025.2477287. Epub 2025 Apr 3.
3
PINCH-1 promotes tumor growth and metastasis by enhancing DRP1-mediated mitochondrial fission in head and neck squamous cell carcinoma.PINCH-1通过增强动力相关蛋白1(DRP1)介导的线粒体分裂促进头颈部鳞状细胞癌的肿瘤生长和转移。
Cancer Biol Ther. 2025 Dec;26(1):2477365. doi: 10.1080/15384047.2025.2477365. Epub 2025 Mar 11.
4
Hiding in plain sight: NUT carcinoma is an unrecognized subtype of squamous cell carcinoma of the lungs and head and neck.隐匿于众目睽睽之下:NUT癌是一种未被识别的肺及头颈部鳞状细胞癌亚型。
Nat Rev Clin Oncol. 2025 Apr;22(4):292-306. doi: 10.1038/s41571-025-00986-3. Epub 2025 Feb 3.
5
TRIM47 promotes head and neck squamous cell carcinoma malignant progression by degrading XAF1 through ubiquitination.TRIM47 通过泛素化降解 XAF1 促进头颈部鳞状细胞癌的恶性进展。
iScience. 2024 Dec 13;28(1):111590. doi: 10.1016/j.isci.2024.111590. eCollection 2025 Jan 17.
6
Structural insights into the role and targeting of EGFRvIII.EGFRvIII 的作用和靶向的结构见解。
Structure. 2024 Sep 5;32(9):1367-1380.e6. doi: 10.1016/j.str.2024.05.018. Epub 2024 Jun 21.
7
Construction of a prognosis model of head and neck squamous cell carcinoma pyroptosis and an analysis of immuno-phenotyping based on bioinformatics.基于生物信息学构建头颈部鳞状细胞癌焦亡预后模型及免疫表型分析
Transl Cancer Res. 2024 Jan 31;13(1):299-316. doi: 10.21037/tcr-23-922. Epub 2024 Jan 29.
8
Lymphocyte-to-Monocyte Ratio Might Serve as a Prognostic Marker in Young Patients with Tongue Squamous Cell Carcinoma.淋巴细胞与单核细胞比值可能作为年轻舌鳞状细胞癌患者的预后标志物。
J Pers Med. 2024 Jan 30;14(2):159. doi: 10.3390/jpm14020159.
9
Metabolic reprogramming by histone deacetylase inhibition preferentially targets NRF2-activated tumors.组蛋白去乙酰化酶抑制导致代谢重编程,优先靶向 NRF2 激活的肿瘤。
Cell Rep. 2024 Jan 23;43(1):113629. doi: 10.1016/j.celrep.2023.113629. Epub 2023 Dec 30.
10
Towards system genetics analysis of head and neck squamous cell carcinoma using the mouse model, cellular platform, and clinical human data.针对头颈部鳞状细胞癌,采用小鼠模型、细胞平台和临床人体数据进行系统遗传学分析。
Animal Model Exp Med. 2023 Dec;6(6):537-558. doi: 10.1002/ame2.12367. Epub 2023 Dec 21.

本文引用的文献

1
Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid Tumors.JNJ-42756493 是一种口服泛成纤维细胞生长因子受体抑制剂的 I 期剂量递增研究,用于治疗晚期实体瘤患者。
J Clin Oncol. 2015 Oct 20;33(30):3401-8. doi: 10.1200/JCO.2014.60.7341. Epub 2015 Aug 31.
2
Characterization of HPV and host genome interactions in primary head and neck cancers.原发性头颈癌中HPV与宿主基因组相互作用的特征分析
Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15544-9. doi: 10.1073/pnas.1416074111. Epub 2014 Oct 13.
3
Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.人乳头瘤病毒阳性和阴性头颈部鳞状细胞癌的综合与比较基因组分析
Clin Cancer Res. 2015 Feb 1;21(3):632-41. doi: 10.1158/1078-0432.CCR-13-3310. Epub 2014 Jul 23.
4
Clinical, genomic, and metagenomic characterization of oral tongue squamous cell carcinoma in patients who do not smoke.不吸烟患者口腔舌鳞状细胞癌的临床、基因组和宏基因组特征
Head Neck. 2015 Nov;37(11):1642-9. doi: 10.1002/hed.23807. Epub 2014 Aug 23.
5
Squamous cell carcinoma of the oral tongue in young non-smokers is genomically similar to tumors in older smokers.年轻非吸烟者舌部鳞状细胞癌在基因组方面与老年吸烟者的肿瘤相似。
Clin Cancer Res. 2014 Jul 15;20(14):3842-8. doi: 10.1158/1078-0432.CCR-14-0565. Epub 2014 May 29.
6
Landscape of genomic alterations in cervical carcinomas.宫颈癌基因组改变的全景。
Nature. 2014 Feb 20;506(7488):371-5. doi: 10.1038/nature12881. Epub 2013 Dec 25.
7
Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability.全基因组分析 HPV 整合在人类癌症中揭示了反复出现的、局部的基因组不稳定性。
Genome Res. 2014 Feb;24(2):185-99. doi: 10.1101/gr.164806.113. Epub 2013 Nov 7.
8
Integrative radiogenomic profiling of squamous cell lung cancer.鳞状细胞肺癌的综合放射基因组分析。
Cancer Res. 2013 Oct 15;73(20):6289-98. doi: 10.1158/0008-5472.CAN-13-1616. Epub 2013 Aug 26.
9
Inhibitor-sensitive FGFR2 and FGFR3 mutations in lung squamous cell carcinoma.肺鳞状细胞癌中抑制剂敏感的 FGFR2 和 FGFR3 突变。
Cancer Res. 2013 Aug 15;73(16):5195-205. doi: 10.1158/0008-5472.CAN-12-3950. Epub 2013 Jun 20.
10
EGFR-directed treatments in SCCHN.头颈部鳞状细胞癌中针对表皮生长因子受体的治疗
Lancet Oncol. 2013 Jul;14(8):672-3. doi: 10.1016/S1470-2045(13)70215-8. Epub 2013 Jun 6.